Swiss National Bank’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-115,300
Closed -$5.09M 2395
2025
Q1
$5.09M Sell
115,300
-1,500
-1% -$69K ﹤0.01% 1247
2024
Q4
$4.22M Buy
116,800
+8,000
+7% +$280K ﹤0.01% 1438
2024
Q3
$3.49M Hold
108,800
﹤0.01% 1530
2024
Q2
$4.1M Buy
108,800
+16,400
+18% +$690K ﹤0.01% 1395
2024
Q1
$4.55M Hold
92,400
﹤0.01% 1354
2023
Q4
$3.37M Buy
92,400
+16,800
+22% +$438K ﹤0.01% 1529
2023
Q3
$1.75M Buy
75,600
+700
+0.9% +$19.1K ﹤0.01% 1923
2023
Q2
$1.96M Buy
74,900
+900
+1% +$23.6K ﹤0.01% 1898
2023
Q1
$1.9M Buy
74,000
+8,400
+13% +$245K ﹤0.01% 1869
2022
Q4
$1.71M Buy
65,600
+1,200
+2% +$29.6K ﹤0.01% 1993
2022
Q3
$1.84M Buy
64,400
+600
+0.9% +$17.2K ﹤0.01% 1932
2022
Q2
$1.57M Buy
63,800
+17,200
+37% +$629K ﹤0.01% 2087
2022
Q1
$2.63M Buy
46,600
+3,400
+8% +$195K ﹤0.01% 1879
2021
Q4
$2.68M Hold
43,200
﹤0.01% 1865
2021
Q3
$2.74M Hold
43,200
﹤0.01% 1846
2021
Q2
$3.56M Sell
43,200
-1,400
-3% -$106K ﹤0.01% 1729
2021
Q1
$3.28M Buy
44,600
+1,400
+3% +$110K ﹤0.01% 1707
2020
Q4
$3.13M Buy
43,200
+14,000
+48% +$901K ﹤0.01% 1653
2020
Q3
$1.39M Buy
29,200
+400
+1% +$17K ﹤0.01% 1902
2020
Q2
$1.21M Buy
+28,800
New +$1.02M ﹤0.01% 1997

Other funds holding SWTX

Swiss National Bank's SWTX Position: Q2 2025 in Review

Swiss National Bank sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 115,300 shares — an estimated $5.09M sold.

Swiss National Bank first reported a position in SWTX in Q2 2020 and held it in 20 quarters. The position peaked at $5.09M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Swiss National Bank reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 115,300 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.09M.
  • Swiss National Bank first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 20 quarters.
  • Swiss National Bank's SpringWorks Therapeutics position peaked at $5.09M in Q1 2025.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.